News & Events
Displaying 1 - 16 of 16
Displaying 1 - 16 of 16
Department of Surgery staff and faculty receive 2022 Chancellor Awards for Diversity
UCSF Department of Surgery
October 27, 2022
Committed to Diversity, Equity, and Inclusion UCSF and the Department and Surgery are committed to building a broadly diverse community, nurturing a culture that is welcoming and supportive, and engaging diverse ideas for the provision of culturally competent education, discovery, and patient care. Chancellor...
Simone received Lloyd M. Kozloff Fellowship
Willenbring Lab
June 08, 2020
The Lloyd M. Kozloff Fellowship rewards excellence in research. Prior academic achievements and potential for future contributions to the health sciences also are considered.
Feng received Liver Center Pilot/Feasibility Grant
Willenbring Lab
June 01, 2020
The Pilot/Feasibility Award Program provides seed money to investigators who are attempting to launch new liver-related research projects. The program supports both clinical and basic research relevant to the liver. The goal of the program is to enable investigators to test new hypotheses and obtain preliminary...
Pervin passed her qualifying exam and is now a PhD candidate in the Tetrad graduate program
Willenbring Lab
May 29, 2020
The qualifying exam is an important checkpoint meant to show that a graduate student is on a promising research track toward the Ph.D. degree. It is a university examination with the specific purpose of demonstrating that the student is clearly an expert in those areas of the discipline that have been specified...
Marko received a Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG)
Willenbring Lab
May 26, 2020
DFG Research Fellowships are intended to help early career researchers to conduct a defined project at a location of their choice in a country other than Germany and to use it as an opportunity to familiarize themselves with new research methods or to bring a large project to a conclusion.
Simone received an NIH Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NRSA)
Willenbring Lab
May 12, 2020
The purpose of the Kirschstein-NRSA program is to enable promising predoctoral students with potential to develop into a productive, independent research scientist to obtain mentored research training while conducting dissertation research.
Nature Article by Willenbring Lab Demonstrates How Liver Cells Switch Identities to Grow New Tissue
Willenbring Lab
June 14, 2018
In the medieval ages, alchemists dedicated their lifetimes searching for the formula that would transform ordinary metals into gold. In our bodies, several cases of “cellular alchemy” have been reported. Known as transdifferentiation, this process consists of one specialized cell type transmuting into a different...
Holger Willenbring Receives Discovery Stage Research Projects Award from CIRM
Willenbring Lab
July 08, 2017
Holger Willenbring, MD, PhD is the receipient of a Discovery Stage Research Project award from the California Institute for Regenerative Medicine (CIRM). The project " Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis" was approved for $1...
NIH Awards Department of Surgery T32 Training Grant for Transplant Surgery
UCSF Department of Surgery
January 06, 2017
The NIH has awarded the UCSF Department of Surgery a T32 training grant , “Filling a Void of Research Training for Transplant Surgeons” (FAVOR). The grant, awarded in August 2016, provides annual funding in the amount of $156,602 for in-depth training of three general surgery residents with an interest in...
Researchers Convert Cirrhosis-Causing Cells to Healthy Liver Cells in Mice
Willenbring Lab
June 03, 2016
UCSF News reports on the research of the Willenbring Lab and others demonstrating in mice that healthy new liver cells could be generated within the organ itself, thus making engraftment unnecessary. The article noted that the very cells that drive liver disease were converted, thereby reducing liver damage and...
Garrett Roll Joins Division of Transplant Surgery
UCSF Transplant Surgery
October 16, 2015
The UCSF Division of Transplant Surgery is pleased to announce that Garrett R. Roll, M.D., FACS, recently joined the division as Assistant Professor Of Clinical Surgery. Dr. Roll is a transplant surgeon specializing in kidney, liver and pancreas transplantation, and in hepatobiliary surgery. Dr. Roll attended...
Scientists Transform Skin Cells into Functioning Liver Cells
Willenbring Lab
February 23, 2014
A recent paper in the journal Nature, reported by UCSF News by a research team including Associate Professor Holger Willenbring, M.D., Ph.D. and Senior Resident Jack Harbell, M.D., a former postdoctoral fellow in the Willenbring lab, reports a new method of cellular reprogramming with potential for treating liver...
Deadly Liver Cancer May Be Triggered by Cells Changing Identity, UCSF Study Shows
Willenbring Lab
July 16, 2012
Intrahepatic bile duct cancer, a rare and deadly form of cancer, known formally as cholangiocarcinoma, has been assumed to derive from cells in the bile ducts of the liver. However, a n international team, led by Holger F. Willenbring, M.D., Ph.D., Associate Professor of Developmental and Stem Cell Biology in the...
Rescuing Liver Function in Patients at Risk of Liver Failure
Willenbring Lab
October 22, 2010
UCSF scientists have received two large grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. A team led by Mark Zern, MD, of the University of California, Davis, and including co-principal...
International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease
Willenbring Lab
May 14, 2008
"International Stem Cell Corporation announced today that its human parthenogenetic stem cell lines will be used in studies aimed at creating liver cells to treat human liver disease. ...... Holger Willenbring, MD, UCSF assistant professor of surgery, will direct the research. "The fact that Dr. Willenbring and...
UCSF Surgeons Discuss Embryonic Stem Cells as Treatment of Liver Disease on PBS NewsHour
UCSF Department of Surgery
October 08, 2007
Dr. Nancy Ascher and Dr. Holger Willenbring were interviewed by PBS NewsHour correspondent Spencer Michaels about the transformation of embryonic stem cells into new liver cells as a treatment for patients.